The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer
AUTOR(ES)
Scheffel, Rafael Selbach
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
13/05/2019
RESUMO
Documentos Relacionados
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid Cancer
- A new mechanism of BRAF activation in human thyroid papillary carcinomas
- The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients
- The impact of the genetic background in a patient with papillary thyroid cancer and familial adenomatous polyposis
- Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer